Soligenix
SNGX
#10565
Rank
โ‚ฌ5.86 M
Marketcap
0,40ย โ‚ฌ
Share price
7.17%
Change (1 day)
-75.63%
Change (1 year)

Earnings for Soligenix (SNGX)

Earnings in 2025 (TTM): -โ‚ฌ11.18 Million

According to Soligenix's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -โ‚ฌ8.09 Million a decrease over its 2023 earnings that were of -โ‚ฌ6.58 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Soligenix from 1998 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -โ‚ฌ11.18 Million38.12%
2024 -โ‚ฌ8.09 Million22.96%
2023 -โ‚ฌ6.58 Million-45.74%
2022 -โ‚ฌ12.13 Million11.88%
2021 -โ‚ฌ10.84 Million-32.37%
2020 -โ‚ฌ16.03 Million83.18%
2019 -โ‚ฌ8.75 Million11.57%
2018 -โ‚ฌ7.84 Million19.29%
2017 -โ‚ฌ6.58 Million33%
2016 -โ‚ฌ4.95 Million-19.7%
2015 -โ‚ฌ6.16 Million5.16%
2014 -โ‚ฌ5.86 Million
2010 -โ‚ฌ6.61 Million26.12%
2009 -โ‚ฌ5.24 Million75.1%
2008 -โ‚ฌ3 Million-45.38%
2007 -โ‚ฌ5.48 Million-22.84%
2006 -โ‚ฌ7.1 Million66.15%
2005 -โ‚ฌ4.28 Million-16.65%
2004 -โ‚ฌ5.13 Million13.28%
2003 -โ‚ฌ4.53 Million-11.88%
2002 -โ‚ฌ5.14 Million-59.44%
2001 -โ‚ฌ12.66 Million378.18%
2000 -โ‚ฌ2.65 Million-38.53%
1999 -โ‚ฌ4.31 Million-18.43%
1998 -โ‚ฌ5.28 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
โ‚ฌ22.47 B-210,134.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
โ‚ฌ9.16 B-85,726.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
โ‚ฌ6.62 B-62,017.23%๐Ÿ‡ซ๐Ÿ‡ท France
Onconova Therapeutics
ONTX
-โ‚ฌ15.72 Million 46.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Athersys
ATHX
-โ‚ฌ36.14 Million 237.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
โ‚ฌ1.96 B-18,460.57%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Cleveland BioLabs
CBLI
-โ‚ฌ2.39 Million-77.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
โ‚ฌ0.14 B-1,436.42%๐Ÿ‡บ๐Ÿ‡ธ USA